REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/17/2025
Back to search
Official data from USPTO
NEURIMMUNE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
68
Latest update
11/18/2025
Trademark type
Combined
Nice classes
5, 42, 44
Filing date
03/03/2018
Registration date
11/17/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/17/2020
Last transaction
11/18/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
3
Owner type
99
Owner location
Schlieren, CH
Examiner
HILL,JAMES T
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "NEURIMMUNE" above a design consisting of four lines. Two diagonal lines in opposite directions converge to become parallel horizontal lines. The diagonal portions of the lines are flanked by one additional diagonal parallel line each.
Holders and representatives
Holders
Neurimmune Holding AG
Representatives
Janice Housey
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical preparations for treating diseases of the nervous systeminfectious diseasesneoplasmsdiseases of the immune systemendocrine and metabolic diseasesdiseases of the circulatory systemdiseases of the eye; veterinary preparations for treating diseases of the nervous systeminfectious diseasesneoplasmsdiseases of the immune systemendocrine and metabolic diseasesdiseases of the circulatory systemdiseases of the eye; pharmaceutical preparations for immunotherapeutic purposes; pharmaceutical agents for the removal of tumors; pharmaceutical preparations for the treatment of neurodegenerative diseases; pharmaceutical preparationsimmunogens; pharmaceutical preparationsantibodies for use in disease testing; vaccines; diagnostic preparations for medical purposes in the form of epitopes for detection of anomalies in proteins; pharmaceutical preparationssynthetic peptides for use in the treatment of diseases of the CNSmetabolic diseasescardiovascular diseasescancerpsychiatric diseasesinfections; sanitary preparations for medical use; biological pharmaceutical and veterinary preparations for medical use being for the treatment of diseases of the CNSmetabolic diseasescardiovascular diseasescancerpsychiatric diseasesinfections; pharmaceutical and veterinary biocides; diagnostic preparations for medical and veterinary purposes; sanitary towels for hygiene purposes; dietetic foods adapted for medical use; dietetic beverages adapted for medical use; biological pharmaceutical and veterinary preparations in the nature of protein antibodies targeting specific epitopes of proteins for use in the treatment of diseases of the CNSmetabolic diseasescardiovascular diseasescancerpsychiatric diseasesinfectionsimmunologic diseasesinflammatory diseasesrespiratory diseasespsychological diseases for medical purposes; antibacterial pharmaceutical and veterinary preparationsantibacterial substances for medical purposesantibacterial pharmaceuticals; biopharmaceutical preparations for the treatment of cancer; protein dietary supplements
Class 42
monitoringinspectionanalysis of biologically active chemical substances for quality control purposes; research on pharmaceutical productscosmetics and foodstuffs for others; consultancy and information services in the field of monitoring and inspection for the quality control and analysis of biologically active chemical substances; research in the field of medical treatment and methods; research in the fields of biotechnology and antibodies; medical and scientific research information in the field of clinical trial testing and research in medical treatment; research in the field of sanitary care; monitoring and inspection of biological synthesis and pharmaceutical manufacturing for quality control and scientific research purposes and research in the field of biology; computer software design; computer programming; maintenance of computer software; design and development of computer hardware; development of computer software; consultancy and provision of information relating to quality control of pharmaceutical preparations; scientific research in the field of cancerous diseases; scientific research relating to chemistry
Class 44
medical services; medical services in the field of immunity; provision of medical information; medical examinationsphysical examination for medical purposes; preparation of medicinespharmaceutical compounding services and dispensing of medicines in the nature of pharmaceuticals; healthcare services in the nature of nutritional and dietary consultancy; consultancy and provision of information in the field of sanitary careproviding sanitary health care information; veterinary services; beauty salon services; care services for animalsveterinary care services; hygienic care; consultancy and provision of medical information relating to the operationpreparationadministration and dosage of pharmaceutical preparations; advisory services relating to pharmaceuticals; providing medical information to healthcare professionals and patients in the form of compiled medical reports in the field of diagnosticprophylactic and therapeutic properties of pharmaceuticals; drug use screening services for medical purposes; information services relating to health care
Publications
History of USPTO decisions and trademark events.
68 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/19/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/19/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/19/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/12/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
05/12/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/12/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/12/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/12/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/12/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/10/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/10/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/10/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/21/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/21/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/21/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/21/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/21/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/21/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/21/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/21/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/21/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
11/17/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/01/2020
PUBO
PUBLISHED FOR OPPOSITION
09/01/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/12/2020
CNEA
EXAMINERS AMENDMENT MAILED
07/27/2020
XAAP
EXAMINER'S AMENDMENT AFTER PUB APPROVAL
07/27/2020
OTHE
CASE RETURNED TO EXAMINATION
07/14/2020
IUCN
NOTICE OF ALLOWANCE CANCELLED
07/14/2020
ATRQ
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
07/02/2020
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
07/02/2020
APET
ASSIGNED TO PETITION STAFF
07/02/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/02/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/02/2020
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
05/26/2020
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
05/26/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/21/2020
EX3G
SOU EXTENSION 3 GRANTED
04/18/2020
EXT3
SOU EXTENSION 3 FILED
04/18/2020
EEXT
SOU TEAS EXTENSION RECEIVED
04/18/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/03/2019
EX2G
SOU EXTENSION 2 GRANTED
10/01/2019
EXT2
SOU EXTENSION 2 FILED
10/01/2019
EEXT
SOU TEAS EXTENSION RECEIVED
10/01/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/13/2019
EX1G
SOU EXTENSION 1 GRANTED
04/11/2019
EXT1
SOU EXTENSION 1 FILED
04/11/2019
EEXT
SOU TEAS EXTENSION RECEIVED
04/11/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/30/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/04/2018
PUBO
PUBLISHED FOR OPPOSITION
09/04/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/15/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/27/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
07/27/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/27/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
07/27/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/27/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/16/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/15/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/15/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/22/2018
GNRT
NON-FINAL ACTION E-MAILED
06/22/2018
CNRT
NON-FINAL ACTION WRITTEN
06/22/2018
DOCK
ASSIGNED TO EXAMINER
06/15/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
03/10/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/09/2018
NWAP
NEW APPLICATION ENTERED
03/07/2018
Continuous trademark protection
Get notified about every new filing that threatens NEURIMMUNE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.